Compugen Ltd. (CGEN)
 NASDAQ: CGEN · Real-Time Price · USD
 1.650
 0.00 (0.00%)
  At close: Oct 30, 2025, 4:00 PM EDT
1.670
 +0.020 (1.21%)
  After-hours: Oct 30, 2025, 7:57 PM EDT
Compugen Market Cap
Compugen has a market cap or net worth of $154.33 million as of October 30, 2025. Its market cap has increased by 2.62% in one year.
Market Cap 
 154.33M
Enterprise Value 
 63.43M
1-Year Change 
 2.62%
Ranking 
 Category 
 Stock Price 
$1.65
Market Cap Chart
Since December 31, 2002, Compugen's market cap has increased from $46.50M to $154.33M, an increase of 231.90%. That is a compound annual growth rate of 5.39%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 154.30M | 12.63% | 
| Dec 31, 2024 | 137.00M | -21.58% | 
| Dec 29, 2023 | 174.70M | 181.77% | 
| Dec 30, 2022 | 62.00M | -82.82% | 
| Dec 31, 2021 | 360.80M | -64.38% | 
| Dec 31, 2020 | 1.01B | 183.96% | 
| Dec 31, 2019 | 356.70M | 220.49% | 
| Dec 31, 2018 | 111.30M | -12.91% | 
| Dec 29, 2017 | 127.80M | -50.45% | 
| Dec 30, 2016 | 257.90M | -19.68% | 
| Dec 31, 2015 | 321.10M | -5.97% | 
| Dec 31, 2014 | 341.50M | 4.27% | 
| Dec 31, 2013 | 327.50M | 91.74% | 
| Dec 31, 2012 | 170.80M | 1.73% | 
| Dec 30, 2011 | 167.90M | 3.83% | 
| Dec 31, 2010 | 161.70M | 16.92% | 
| Dec 31, 2009 | 138.30M | 1,033.61% | 
| Dec 31, 2008 | 12.20M | -72.95% | 
| Dec 31, 2007 | 45.10M | -37.45% | 
| Dec 29, 2006 | 72.10M | -38.95% | 
| Dec 30, 2005 | 118.10M | -14.61% | 
| Dec 31, 2004 | 138.30M | 4.38% | 
| Dec 31, 2003 | 132.50M | 184.95% | 
| Dec 31, 2002 | 46.50M | - | 
| Dec 31, 2002 | 46.50M | - | 
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 730.33B | 
| Johnson & Johnson | 449.57B | 
| AbbVie | 397.72B | 
| UnitedHealth Group | 321.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 216.57B |